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Between 70 and 95% of urinary tract infections (UTI) are caused by strains of Escherichia
coli. These strains, often termed Extraintestinal Pathogenic E. coli (ExPEC), possess
specific virulence traits allowing them to colonize more inhospitable environments, such
as the urogenital tract. Some ExPEC isolates from humans have similar virulence factor
profiles to ExPEC isolates from animals, and because of the potential for these strains
to cause UTI in people, these infections have been referred to as foodborne UTI, or
FUTI. Finding similarities in ExPEC in animals and humans is not necessarily proof of
transmission, particularly a unidirectional pathway from animals to humans; similarities in
virulence factor profiles should be expected given the specific bacterial requirements for
colonizing physiological compartments with similar characteristics in all animals. Many of
the most important strains of human ExPEC globally, such as ST131, are highly virulent
and clonal implying routes of transmission other than food. Documenting routes of
transmission is particularly difficult due to the wide range of potential ExPEC sources,
including the human intestinal tract, and non-human reservoirs such as food animals and
retail meat products, sewage and other environmental sources, and companion animals.
The significant environmental reservoir of ExPEC, including strains such as ST131, could
potentially explain much more completely the global dissemination of virulent ExPEC
clones and the rapid dissemination of new strains within the community. Taken in its
totality, the link between ExPEC in animals and UTI in humans might exist, but studies
conducted to date do not enable an estimation of the relative importance of this route
of transmission. To reduce the burden of illness associated with ExPEC, the scientific
community needs to push forward with ecologically-based, scientifically-sound study
designs that can address the plethora of ways in which E. coli can spread.
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INTRODUCTION
Extraintestinal pathogenic Escherichia coli (ExPEC) is an incredi-
bly diverse E. coli pathotype, and this genetic diversity is reflective
of its occurrence in and colonization of diverse and highly special-
ized ecological niches. These strains, which can reside in the gas-
trointestinal (GI) tract, differ from normal commensal strains in
that they possess virulence traits that allow them to colonize more
inhospitable environments, such as the urogenital tract (Smith
et al., 2007). Aside from these bacteria-specific traits, host-specific
factors are also required for disease. For this reason, ExPEC is
considered a necessary but not sufficient cause for extraintestinal
E. coli infection, meaning that additional factors are required for
illness to occur (Rothman et al., 2008). Consequently, ExPEC is
considered an opportunistic pathogen for causing ExPEC-related
illness.
In general, ExPEC can colonize the human intestine, and
when given the opportunity in individuals who might be vul-
nerable in some way (e.g., compromised immune system) or
the presence of specific risk factors such as increased sexual
activity and use of spermicides (Foxman, 2014), the bacterium
can be transferred to the urogenital tract where it can cause a
urinary tract infection (UTI). UTIs represent a serious burden
of illness globally (Foxman, 2002, 2014), and 70–95% of these
infections are caused by strains of E. coli (George and Manges,
2010; Hooton, 2012), often termed uropathogenic E. coli (UPEC),
which is a subset of ExPEC. Although antibiotic treatment is only
necessary in some cases of UTI, antibiotic resistant infections
can increase the costs associated with treatment (Alam et al.,
2009). Resistance to antibiotics that are important for treating
UPEC infections has been steadily increasing (Nordstrom et al.,
2013).
The time between GI colonization and subsequent extrain-
testinal infection can be lengthy, with some studies using a
6-month risk window for development of the UTI (Manges
et al., 2007). This extended timeframe between exposure to an
ExPEC strain and subsequent illness makes it very challenging
to establish a “source” for the strain given the constant ebb and
flow of E. coli strains within human and animal GI tracts. In a
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classic study of E. coli variability, E. coli populations in the GI
tract of the human host changed frequently over time through
clonal replacement, but the ecological and genetic reasons for
these changes were never clarified (Caugant et al., 1981). Similar
observations of a high rate of E. coli turnover in the GI tract have
also been made in animal populations (Hinton, 1986; Hinton
et al., 1986).
It is well-accepted that bacteria such as E. coli can move pas-
sively to humans through a variety of routes, including the food
chain. Because of the similarity between some human and animal
ExPEC and the potential for these strains to cause UTI in people,
these infections have recently been referred to as foodborne UTI,
or FUTI (Nordstrom et al., 2013). However, finding similarities
in ExPEC in animals and humans is not necessarily proof of
transmission, in general, or in a unidirectional pathway from
animals to humans, specifically. Similarities in strains isolated
from different host species should be expected, particularly with
respect to specific virulence factors (VF). These VF are important
to ExPEC survival in these extraintestinal environments. Further-
more, while it is commonly assumed that the use of antimicrobials
in animal agriculture is the primary cause of antibiotic resistance
(AR) observed in many human UPEC strains, the presence of
AR traits within these bacteria is not proof of a cause and effect
relationship with antimicrobial use in animal agriculture. Overall,
phenotypic trait typing may not reflect underlying genetic dissim-
ilarity, and even in the event of documenting identical genotypes
among hosts, a common source cannot be determined without
appropriate study design.
A continued reliance on phenotypic traits, such as VF and
AR, and the use of study designs inappropriate for documenting
frequency and direction of transmission, has resulted in the
propagation of the ill-defined inference that animal ExPEC cause
a substantial fraction of human ExPEC infections, including UTI.
This review will explore the complexities of interpreting ExPEC-
related data with respect to distribution, illness and transmission.
The attribution of ExPEC-associated UTIs to specific sources,
including the potential for a causal link between animal ExPEC
and human UTI, will be discussed. Finally, this review will high-
light study design issues that should be considered to provide
better insight into the serious global burden of ExPEC-related
illness.
UPEC AND UTI IN THE COMMUNITY
Urinary tract infections are generally considered sporadic ill-
nesses within the community. Some researchers believe that there
have been outbreaks of UTIs within communities (George and
Manges, 2010), including south London (Phillips et al., 1988),
Copenhagen (Olesen et al., 1994), Calgary (Pitout et al., 2005),
and California (Manges et al., 2001). These case series, which
often involve a diverse set of strains within a clonal group, lack
a clear definition of what constitutes an outbreak. For example,
in a purported outbreak of UTIs caused by ExPEC in clonal
group A (CgA), which as a group can lead to bacteremia (Skjot-
Rasmussen et al., 2013), the isolates actually belonged to four
different serotypes (Manges et al., 2006). Infection in the commu-
nity with commonly circulating ExPEC strains is normally not a
sufficient outbreak definition, particularly with an opportunistic
pathogen, if the overall burden of illness (incidence of UTI within
the community) does not differ from the expected rate. As stated
in a publication regarding outbreak defintions, genotype data are
used to support the epidemiolgoical data in defining an outbreak
(Riley and Manges, 2005), but simply having a common set of
genotypes in a specific time and place is not sufficient for defining
an outbreak with an opportunistic pathogen.
Reports of purported UTI outbreaks have been interpreted
as being consistent with the introduction of these new strains
into the community through a single point source, such as food.
However, these reports are also consistent with regular, broad
clonal shifts in the endemic ExPEC strains within the commu-
nity. When data on the predominant UPEC strains within the
community are assessed over time, newly identified strains can
become endemic and then persist for extended temporal periods
(Manges et al., 2008). A study in a single community (Smith et al.,
2008) noted shifts in the predominant UTI-associated strains over
time, a finding that might be more consistent with horizontal
transmission or widespread exposure to a common source such
as water rather than a limited food item. It would be plausible to
have a strain introduced via a limited food vehicle such as meat
and then disseminated more broadly via human-to-human or
environment-to-human transmission. Regardless, this constant
turnover in E. coli should not be considered synonymous with
continual outbreaks linked to novel strains.
Because of the potential to have some of these strains intro-
duced into a community via food, some investigators have stated
that a potential common source of UPEC is analogous to an
E. coli O157:H7 outbreak (Manges et al., 2006). E. coli O157 and
other EHEC strains cause severe GI infection soon after ingestion;
extended colonization of the healthy human host with these
strains is rare as is person-to-person transmission. This situation
is very different from UTIs caused by ExPEC that colonize the
healthy human, where person to person transmission may be the
primary mode of movement of these strains. These situations are
not analogous, and comparing them can be misleading. Applying
outbreak definitions from organisms like E. coli O157 to ExPEC-
related UTIs is entirely inappropriate.
Of considerable and justified concern is the global dissemina-
tion of highly virulent ExPEC clones over the past decade (Petty
et al., 2014; Riley, 2014), including the clonal complex known
as sequence type 131 (ST131) which now causes the majority
of extraintestinal infections in humans, including UTI (Nicolas-
Chanoine et al., 2008; Novais et al., 2012; Price et al., 2013).
This clonal complex is thought to be highly virulent and is com-
monly multidrug resistant, including resistance to the critically
important antibiotic classes of fluoroquinolones and third and
fourth generation cephalosporins. The transmission pathways for
these clones to disseminate globally remain unclear. The ST131
pandemic in humans appears to have little relationship to animal
agriculture, at least in its origins, and likely emerged through
evolutionary pressures in human hospitals and the community
(Platell et al., 2011b; Johnson et al., 2012a). This strain is also
found in companion animals, including pets that share residence
with humans (Ewers et al., 2010; Platell et al., 2010, 2011a; Osugui
et al., 2014) and has been documented to spread among dogs
and cats within the household (Johnson et al., 2009d). While
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the possibility for horizontal transfer of virulence genes among
E. coli exists (Johnson and Nolan, 2009), the global distribution of
these highly virulent clones in multiple hosts and clear evidence
of direct horizontal transmission among hosts would appear to
make food an unlikely vehicle by which to explain this pattern of
disease.
HUMAN AND ANIMAL EXTRAINTESTINAL E. coli
The establishment of extraintestinal disease by ExPEC is complex,
usually involving strains carrying necessary VF first colonizing the
GI tracts of individuals at-risk for disease (Moreno et al., 2008).
There are no concrete criteria, however, for defining an E. coli
strain as ExPEC. Some groups have made the assumption that
possessing at least two of the following genetic determinants war-
rants the ExPEC label: papA and/or papC (P fimbriae structural
subunit and assembly), sfa/focDE (S and F1C fimbriae), afa/draBC
(Dr binding adhesins), iutA (aerobactin system), and kpsM II
(type II capsule; Johnson et al., 2007a). This minimal predictive
set of ExPEC virulence genes is based upon genotyping of many
virulence-associated genes, but this subjective definition has not
been thoroughly validated, as strains meeting this definition do
not always cause disease. Using a list of known VF as a criterion
misses the remaining genes in the pathogen’s genome that may
also be required for disease, but these might not be in all strains
with the “correct” VF distribution.
Given the fact that ExPEC require specific VF to cause disease
in animals, it should be expected that there will be similarities
in ExPEC across animal species. This is particularly true if the
total array of possible VF is reduced to the minimal predictive
set described previously. The niches that the ExPEC strains col-
onize extraintestinally require specific bacterial adaptations, and
because some of these requirements are similar across animals,
similarities in the subsets of VF necessary for causing extrain-
testinal disease in different animal hosts are expected. Among
E. coli that cause extraintestinal disease in poultry, also known
as avian pathogenic E. coli (APEC), similarities in VF profiles
have been observed with the human ExPEC strains (Rodriguez-
Siek et al., 2005; Johnson et al., 2008a; Belanger et al., 2011;
Danzeisen et al., 2013). Similarity in VF profiles of ExPEC from
companion animals and humans has also been observed (Johnson
et al., 2009a).
Extraintestinal Pathogenic E. coli from both animals and
humans have been shown to have the ability to cross host species
barriers. In mouse models, APEC and human ExPEC strains were
shown to have UTI-causing ability (Jakobsen et al., 2010a, 2012).
Neonatal meningitis caused by E. coli (NMEC) is a serious and
often fatal disease. In rat models, APEC strains were capable of
causing meningitis (Tivendale et al., 2010), although considerable
work still needs to be performed to fully understand virulence
requirements in these isolates (Logue et al., 2012). Human ExPEC
strains have also been shown to be virulent for chicks (Moulin-
Schouleur et al., 2007). Continued research in the area of VF is
needed to determine specific VF required for disease in different
hosts, factors that select for increasing virulence, and the fre-
quency with which ExPEC isolates cross the host-species barrier
in the real world. This topic will be discussed further in the Source
Attribution section below.
ANIMAL ANTIBIOTIC USE, ANTIBIOTIC RESISTANCE, AND
THE RELATIONSHIP TO HUMAN UTI
Perhaps the most confounding aspect of the discussion of human
UTI related to foodborne transmission and animal agriculture
is the issue of antibiotic use and resistance. The concern over
antibiotic resistant strains of UPEC is warranted given that resis-
tance to the antibiotics of choice for treating human UTIs has
been observed and some compounds are no longer prescribed
at all because of high resistance rates (Nordstrom et al., 2013).
A number of studies have documented similar AR traits of con-
temporaneously sampled human and animal ExPEC (Johnson
et al., 2007a; Hancock et al., 2009; Jakobsen et al., 2010b; Bergeron
et al., 2012) and have attributed the resistance to antibiotic use
in agriculture. None of these studies has ascertained antibiotic
exposure information and none has used analytical approaches
that would aid in the determination of the origins of resistance.
With findings of identical resistance profiles in E. coli sourced
from antibiotic-free meat sources (Johnson et al., 2007a) and the
absence of data on antibiotic use from other meat sources, these
study designs do not enable conclusions regarding the origins of
the resistance or the selection pressures that may have contributed
to the observed resistance. The presence of similar AR phenotypic
patterns is insufficient for documenting likely transmission, as
discussed below in the Source Attribution section.
The focus of most discussion concerning antibiotic resistant
ExPEC in animals has been on antibiotics used for growth pro-
motion/feed efficiency (Nordstrom et al., 2013; Riley, 2014). The
antibiotics approved for this use, at least in poultry, have little
activity against E. coli or are unrelated to the resistances that
are relevant for treatment of human UTIs. Trimethoprim and
sulfamethoxazole are antibiotics important for treating human
ExPEC infections, but neither is used for growth promotion in the
U.S. Fluoroquinolones such as ciprofloxacin are also important
for treating human UTIs; these compounds have never been
approved for growth promotion and were withdrawn from use
in U.S. poultry in 2005. In fact, the National Antimicrobial
Resistance Monitoring System (NARMS) in the U.S. has only
identified two E. coli isolates from chicken meat with ciprofloxacin
resistance since 2002 (U.S. Food and Drug Administration, Center
for Veterinary Medicine, 2012b). The prevalence of ciprofloxacin
resistance in UPEC has been steadily increasing, with the rate
apparently accelerating even after the withdrawal of fluoro-
quinolones from U.S. poultry (Sanchez et al., 2012). Enrofloxacin
is used in companion animals, and enrofloxacin resistance in
E. coli UTI in dogs has been documented (Cooke et al., 2002).
Although the isolates from this study had VF patterns that differed
from the most common human ExPEC isolates (Johnson et al.,
2009a), transmission between humans and companion animals is
well-documented, as described previously.
Within the U.S., the U.S. FDA Center for Veterinary Medicine
has initiated the process of phasing out of the growth promo-
tion/feed efficiency label for critically important antibiotics over
a 3-year period, to be completed by December 2016 (U.S. Food
and Drug Administration, Center for Veterinary Medicine, 2012a,
2013). Consequently, while more research is needed to clarify
the relationships between remaining on-farm antimicrobial usage
and AR in human pathogens, a continued focus on the growth
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promoters will prevent us from accurately understanding and
mitigating the pandemic crisis of multidrug resistant ExPEC.
Resistance to critically important antibiotics can be frequently
found in ExPEC isolates, including UPEC and APEC. Similarities
in the VF profiles of resistant and susceptible strains from animals
have been interpreted as evidence that resistance develops in
animals because of antibiotic use and is then transferred to people
(Johnson et al., 2007a, 2009b). The conclusions reached in the
study by Johnson et al. (2007a), in particular, are problematic and
not necessarily supported by the data and yet these conclusions
have been widely cited, including in high profile documents such
as the recent President’s Council of Advisors on Science and
Technology (PCAST) report from the Executive Office of the
President of the United States (President’s Council of Advisors
on Science and Technology [PCAST], 2014). For example, in
that study both resistant and susceptible poultry isolates differed
from the human isolates. The principal coordinates analysis that
was based on virulence genotypes and phylogroups showed this
distinction. Because the authors felt that the resistant human
isolates were more similar overall to the poultry isolates than
to the susceptible human isolates, they concluded that the resis-
tant strains in humans must have been derived from poultry.
Furthermore, the finding of similar resistant strains in meat-
eaters and vegetarians was interpreted as consistent with human-
to-human transmission or errors in reporting of poultry con-
sumption rather than human strains being derived from a source
other than chicken. If these illnesses were truly being sourced
from poultry, one would expect to see the susceptible human and
poultry isolates overlapping as well, a finding not supported by
this study. Finally, the observation that resistant and susceptible
poultry ExPEC isolates were similar with respect to virulence
should indicate that resistance is unlinked from virulence, likely
through the gain and loss of resistance-encoding plasmids. This is
not synonymous with the conclusion that resistance develops in
poultry and subsequently spreads to humans. While it is possible
for the virulence traits to be co-located with AR traits within the
bacterium, in avian-source strains it is more common to observe
virulence-associated traits on a plasmid that has no resistance
traits (Johnson et al., 2012b).
SOURCE ATTRIBUTION
It has been stated that to “establish a link between human and
animal ExPEC strains, isolates need to be compared” (Belanger
et al., 2011). However, simply finding similarities between animal
and human isolates is not the same as documenting the routes
of transmission and the frequency by which strains from animals
colonize humans and cause subsequent disease. While the trans-
mission of ExPEC among differing hosts is biologically plausible
given the overlap in VF, this is different than performing the more
arduous task of quantifying the frequency and directionality of
these events. One way to think about source attribution from
a causal perspective, for example between chicken consumption
and UTI, is to ask the question “if no more chicken were con-
sumed, how many E. coli UTIs would be prevented and how much
would the prevalence decline?” Note that this statement sounds
similar to the commonly used epidemiological attributable frac-
tion. The attributable fraction, however, is frequently misinter-
preted; it is typically based on observational data and most often
represents a statistical association and not a causal relationship.
Documenting routes of transmission is particularly difficult
due to the wide range of potential ExPEC sources, including the
human intestinal tract, and non-human reservoirs such as food
animals and retail meat products, sewage and other environmen-
tal sources, and companion animals (Manges and Johnson, 2012).
To identify the important sources and routes of transmission and
to quantify the frequency of these transmission events, more rig-
orous epidemiological methods are needed, including improve-
ments in study design, data analysis and data interpretation in
addition to the incorporation of better molecular methods such
as whole genome sequencing (WGS). A recent paper using E. coli
ST131 as a model demonstrated a novel approach that might
aid in identifying sources and routes of transmission of ExPEC
strains (Lanza et al., 2014), with broad applications discussed in
the accompanying perspective paper (Achtman and Zhou, 2014).
Given that we can only attribute illnesses to sources included
in the study, more attention needs to be given to the inclusion
of diverse sources in overlapping spatial and temporal sampling
frames. Study designs that enable the assessment of human-
to-human and environment-to-human transmission must be
utilized.
In general, most studies that have characterized ExPEC isolates
from humans, both diseased and healthy, and from animals and
animal meats have found that the animal isolates did not have the
exact complement of virulence genes detected in the isolates from
UTIs or the community samples (Ewers et al., 2007; Jakobsen
et al., 2010c; Kluytmans et al., 2013). APEC strains in particular
have some of the same VF as UPEC strains (Johnson et al., 2008a;
Danzeisen et al., 2013; Mora et al., 2013; Maluta et al., 2014),
but when a broad range of VF is assessed, considerable differ-
ences in the VF array of these ExPEC lineages become apparent
(Johnson et al., 2008b; Belanger et al., 2011). This discrepancy
has been acknowledged as consistent with the presence of other
sources of ExPEC virulence genes (Ewers et al., 2007) and could
reflect convergence on a similar set of virulence traits required by
ExPEC in different animal hosts to colonize specialized niches.
Some of these studies included methods such as pulsed-field gel
electrophoresis (PFGE), multilocus sequence typing (MLST), and
suppression subtractive hybridization (SSH) in addition to VF
profiling and found that, while the isolates were similar, there was
a clear distinction between the avian and human subpopulations
(Moulin-Schouleur et al., 2006, 2007; Kariyawasam et al., 2007).
Although many studies have used VF and AR profiles to infer
patterns of transmission, these approaches are inadequate for
establishing transmission events of ExPEC. These methods lack
the necessary resolution for establishing actual similarity of
ExPEC strains among hosts. Similarities in VF and AR in ExPEC
isolated from different animal species could indicate (1) uni-
directional transmission from one species to another, (2) bidi-
rectional transmission between the species, (3) transmission
to each species from a common external source, or (4) com-
pletely independent pathogen transmission pathways, as has
been described in specific subsets of Salmonella enterica (Mather
et al., 2012, 2013). In particular, the analysis by Mather et al.
(2013) that applied WGS to Salmonella Typhimurium DT104
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isolates collected contemporaneously from animals and humans
in Scotland showed distinct bacterial populations in humans
and animals, thus questioning the dogma that this strain was
associated with an epidemic spreading from animals to people.
These types of molecular approaches and analyses are needed
to provide better resolution to the complex ecology of ExPEC
(de Been et al., 2014). A recent study using ST131 as a model
highlighted one approach that might help clarify the complex
distribution and long-distance dissemination of ExPEC strains
such as ST131 (Lanza et al., 2014).
As WGS becomes more commonly employed in epidemio-
logical investigations it will become easier to quantify the likely
overlap of ExPEC populations among different hosts. An early
study using WGS on ExPEC strains found that a prototypical
APEC strain (APEC O1:K1:H7) had over 95% sequence identity
with many human ExPEC whole genome sequences (Johnson
et al., 2007b). A more recent study further demonstrated this
high genomic similarity and showed the ability of APEC strains
to cause meningitis in a neonatal rat model (Zhu Ge et al., 2014).
While these results support the notion that ExPEC in animals and
humans are highly similar, differences of 5% at the genomic level
would not be suggestive of a recent transmission event.
In the 1990’s, as PFGE was gaining increasing usage as a
method for typing bacterial isolates, criteria were established for
interpreting relatedness of isolates collected during an outbreak
and for helping determine if isolates were likely part of the same
outbreak. These relatedness criteria put forth by Tenover et al.
(1995) have been widely used for linking isolates to an outbreak
strain and for suggesting plausible transmission events. Criteria
such as these are needed for interpreting the comparative genomic
analyses that incorporate WGS. For ExPEC isolates collected from
multiple sources in a contemporaneous and spatially overlapping
sampling frame, a better understanding is needed regarding the
expected number of single nucleotide polymorphisms (SNPs) if
the isolates were, in fact, transferred from one source to another.
Evolutionary analytical tools well established in species ecology,
such as phylogenetic diffusion modeling, have been successfully
employed to draw inference about the relatedness of host-specific
bacterial pathogen populations over time (Mather et al., 2013).
Making decisions after the study about the degree of inter-strain
similarity that might constitute source overlap and then making
subjective interpretations of potential transmission based on these
post hoc decisions will only continue the propagation of biased
conclusions relative to ExPEC ecology and disease.
In addition to improving the laboratory and analytical
approaches for studying ExPEC, improvements are needed in
ExPEC study designs. Many studies involving ExPEC assume a
priori that animals are the source of the ExPEC strains infecting
humans and therefore have used a study design that oversam-
ples specific animal commodities. These studies also tend to
assume that antimicrobial resistance is the key trait of interest
and therefore include oversampling of isolates that possess these
resistance traits. By restricting the sampling scheme to very few
sources, and by using biased oversampling techniques, it becomes
impossible to estimate possible source attribution and the rela-
tive importance of one source versus another. These biases are
further compounded by the continued use of typing methods
that lack specificity, such as the exclusive reliance on VF and AR
profiles.
As an example, a series of studies by one research group
oversampled resistant isolates and restricted the range of possible
sources to primarily chicken, beef and pork (Vincent et al., 2010;
Bergeron et al., 2012). The studies presented no data about
individual UTI cases, including the many exposure factors that
increase one’s risk for developing a UTI. Although there were
considerable differences between the isolates collected from UTIs
and meats, the authors found that more isolates from chickens
were in the same clonal groups with UTI isolates than beef cattle
and pigs and thus concluded that this “confirms our hypothesis
that chickens are a likely reservoir for ExPEC in humans” (Berg-
eron et al., 2012, p. 420). To properly evaluate the possible role
of food as a source of human UPEC, finding broad similarities
in the genetic profiles of isolates is insufficient to demonstrate
transmission and source attribution.
The a priori assumption that meat is the source of human
ExPEC is used to justify another study design: the comparison of
ExPEC in meat-eaters and vegetarians. This type of comparison
is typically biased because of the extreme confounding that exists;
in other words, there is the implicit assumption that differences
in the GI bacteria of these two groups can be attributed to the
sole factor of meat consumption. When assessing the individuals
enrolled in these studies, they often differ by many significant
factors, including age and health status, and one early study
found that hospitalization was significantly more important than
diet in predicting the presence of resistant GI bacteria (van den
Braak et al., 2001). In a study that was described above (Johnson
et al., 2007a), the similar ExPEC strains in the healthy vegetarian
comparison group and the hospitalized human group suggests
a common non-meat source or significant human-to human
transmission. The authors concluded, however, that individuals
have trouble recalling poultry exposures and that the isolates were
likely poultry-derived and either ingested inadvertently by the
vegetarians or transmitted from meat-eaters to vegetarians. To
evaluate the importance of animal sources to human ExPEC, bet-
ter comparison groups are required with more detailed exposure
histories recorded throughout the longitudinal investigation.
Perhaps the greatest challenge in understanding the sources
of human UPEC is determining directionality of transmission of
these strains. Most papers studying FUTI assume unidirectional
movement of ExPEC isolates from animals to humans via the
meat supply, even though the importance of human-to-human
transmission is often the best explanation for certain infection
patterns (Johnson et al., 2009c). Realistically, the movement of
these strains likely includes complex environmental dissemina-
tion routes rather than unidirectional from one host species
to another. The global dissemination of highly virulent ExPEC
clones is a clear testament to these more complex transmission
pathways (Petty et al., 2014; Riley, 2014). When WGS is applied
to E. coli from many sources, including natural environments,
our understanding of natural habitat, physiological function, and
sources for potential transmission will undoubtedly change (Luo
et al., 2011).
Given that most E. coli UTIs begin with colonization of the
human intestinal tract by these ExPEC strains before infection
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of the urogenital tract can occur, there will be extensive human
shedding of these ExPEC isolates into the environment via feces.
Studies have shown that E. coli with uropathogenic VF can survive
the sewage treatment plant process (Anastasi et al., 2010) and can
be found in the waters surrounding these sites (Anastasi et al.,
2012). ESBL-producing E. coli, including ST131, have been found
in wastewater treatment plant effluent, demonstrating a clear
environmental loading due to anthropogenic influence (Amos
et al., 2014). As stated in this study, “Whilst it is not possible to
determine the direction of spread from humans to animals, the
significant environmental reservoir in rivers will impact both.”
Some authors have acknowledged the potential role of water as
a source (Belanger et al., 2011), and this could help explain the
finding of antibiotic resistant E. coli, including ST131, in wildlife
(Tausova et al., 2012; Hasan et al., 2014). This significant environ-
mental reservoir could potentially explain much more completely
the global dissemination of virulent ExPEC clones and the rapid
dissemination of new strains within the community. To untangle
the complexity of ExPEC ecology, we must do a better job at
study design and recognize the broad range of potential sources
and routes of transmission. Studies that incorporate proper study
design and WGS, such as the recently published paper on ST131,
are desperately needed (Lanza et al., 2014).
CONCLUSION
Without doubt, there is potential for ExPEC to be transferred to
humans as a result of the mishandling and/or undercooking of
meats. Inadvertent ingestion of these strains leads to the potential
for colonization of the intestinal tract, and if conditions are
right, these strains can then gain entry to the urinary tract in
compromised individuals. The likelihood and frequency of this
occurrence, though, has not been demonstrated.
One approach that would enable the blending of the ecological
and epidemiological aspects of ExPEC and provide a mechanism
by which to investigate the likelihood and frequency of transmis-
sion events is through the integration of modeling efforts with
empirical epidemiology and microbiology in an iterative process
(Restif et al., 2012). This “model-guided fieldwork” framework,
originally proposed in the context of wildlife ecology, dictates that
models should be constructed early and inform all stages of the
investigative effort from generation of hypotheses through the
design of experimental trials and data analysis. Models resulting
from this framework are data driven, specific to the system under
study and able to provide highly useful insights. The end result
of a study designed and performed under this framework is one
that encompasses a range of plausible transmission routes, has
appropriate sampling frames, and utilized laboratory methods
in a manner that facilitates objective inferences about evolution,
transmission and attribution.
As we develop a more ecological perspective to understand
ExPEC transmission, there is a critical need to eliminate con-
firmation bias and subjective scientific inference. Confirmation
bias is the reporting of information or the interpretation of
equivocal results as supporting one’s a priori beliefs at the expense
of alternate and equally plausible options (Borrell-Carrio and
Epstein, 2004; Cox and Popken, 2008). In the case of FUTI
studies, this would result in authors concluding that animals
are the likely reservoir of human UTIs, without considering the
totality of data and by excluding important alternative trans-
mission pathways. Subsequent studies are designed around this
“fact,” thus biasing any future inferences. As stated in one
paper, “the present study population, which consisted of resistant
E. coli only, may have been biased toward chicken-source isolates,
which predictably would confound the ability of discriminant
analysis to accurately predict the true original source of the
isolate” (Kluytmans et al., 2013). Sound ecological investiga-
tions of ExPEC that account for many different possible sources
and many different possible transmission routes are desperately
needed.
The genetic basis of virulence in the ExPEC lineage that has
commonalities in animals and humans, and the potential for
animal ExPEC to cause disease in humans, cannot and should
not be ignored. The reality of ExPEC is that there is likely some
intermixing of strains among diverse animal hosts, likely through
the environment, and thus a more integrated, “One Health” type
of approach to addressing this issue is needed (Ewers et al., 2012).
Because of the animal component, animal health interventions
that target APEC are of the utmost importance. For example,
improvements in APEC vaccine efficacy (Nordstrom et al., 2013)
would aid human health in multiple ways. First, if there is some
connection between APEC and human UTIs, a poultry vaccine
would therefore clearly reduce human illness. Second, reducing
the burden of illness in poultry due to APEC would also reduce
the need for antibiotic treatment of sick flocks, and this reduced
antibiotic usage would have a positive result for both human
and animal health. Models have been developed that assess the
relationship between animal health and human health (Singer
et al., 2007), and these types of risk-benefit models need to be
expanded into ecologically-based risk assessments (Ashbolt et al.,
2013). To reduce the burden of illness associated with ExPEC, the
scientific community needs to push forward with ecologically-
based, scientifically-sound study designs that can address the
plethora of ways in which E. coli can spread. Labeling UTIs
caused by ExPEC as FUTI does nothing to further this mission
and distracts from the holistic approach required to mitigate this
serious global burden of illness.
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